Abstract:The neurotoxic α-synuclein (α-syn) oligomers play an important role in the occurrence and development of Parkinson's disease (PD), but the factors affecting α-syn generation and neurotoxicity remain unclear. We here first found that thrombomodulin (TM) significantly decreased in the plasma of PD patients and brains of A53T α-syn mice, and the increased TM in primary neurons reduced α-syn generation by inhibiting transcription factor p-c-jun production through Erk1/2 signaling pathway. Moreover, TM decreased α-syn neurotoxicity by reducing the levels of oxidative stress and inhibiting PAR1-p53-Bax signaling pathway. In contrast, TM downregulation increased the expression and neurotoxicity of α-syn in primary neurons. When TM plasmids were specifically delivered to neurons in the brains of A53T α-syn mice by adeno-associated virus (AAV), TM significantly reduced α-syn expression and deposition, and ameliorated the neuronal apoptosis, oxidative stress, gliosis and motor deficits in the mouse models, whereas TM knockdown exacerbated these neuropathology and motor dysfunction. Our present findings demonstrate that TM plays a neuroprotective role in PD pathology and symptoms, and it could be a novel therapeutic target in efforts to combat PD. Schematic representation of signaling pathways of TM involved in the expression and neurotoxicity of α-syn. A TM decreased RAGE, and resulting in the lowered production of p-Erk1/2 and p-c-Jun, and finally reduce α-syn generation. α-syn oligomers which formed from monomers increase the expression of p-p38, p53, C-caspase9, C-caspase3 and Bax, decrease the level of Bcl-2, cause mitochondrial damage and lead to oxidative stress, thus inducing neuronal apoptosis. TM can reduce intracellular oxidative stress and inhibit p53-Bax signaling by activating APC and PAR-1. B The binding of α-syn oligomers to TLR4 may induce the expression of IL-1β, which is subsequently secreted into the extracellular space. This secreted IL-1β then binds to its receptor, prompting p65 to translocate from the cytoplasm into the nucleus. This translocation downregulates the expression of KLF2, ultimately leading to the suppression of TM expression. By Figdraw.

Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells.

Inhibition of tyrosine hydroxylase expression in α-synuclein-transfected dopaminergic neuronal cells

Oligomeric Α-Synuclein Inhibits Tubulin Polymerization

RNA Interference Targeting Α-Synuclein Attenuates Methamphetamine-Induced Neurotoxicity in SH-SY5Y Cells

Protective effect of alpha-synuclein knockdown on methamphetamine-induced neurotoxicity in dopaminergic neurons

Study on the toxic effects of Aβ1-42 oligomers in SHSY5Y with human A53T mutant α-synuclein over-expression.

Overexpressed Alpha-Synuclein Regulated the Nuclear Factor-kappaB Signal Pathway

Dopamine Auto-Oxidation Aggravates Non-Apoptotic Cell Death Induced by Over-Expression of Human A53t Mutant Alpha-Synuclein in Dopaminergic Pc12 Cells

Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation.

[The Wild-Type Alpha-Synuclein Over-Expression to Induce the Protein Aberrant Aggregation of Alpha-Synuclein in HEK293 Cells in Vitro].

Thrombomodulin Reduces Α-Synuclein Generation and Ameliorates Neuropathology in a Mouse Model of Parkinson’s Disease

Suppression of Abnormal Α-Synuclein Expression by Activation of BDNF Transcription Ameliorates Parkinson's Disease-Like Pathology.

Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression

1 serine 129 phosphorylation reduces α-synuclein ’ s ability to regulate tyrosine hydroxylase and protein phosphatase 2 a in vitro and in vivo

Serine 129 Phosphorylation Reduces The Ability Of Alpha-Synuclein To Regulate Tyrosine Hydroxylase And Protein Phosphatase 2a In Vitro And In Vivo

Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant α-synuclein

Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration

α-Synuclein promotes clathrin-mediated NMDA receptor endocytosis and attenuates NMDA-induced dopaminergic cell death.

Dyrk1a Phosphorylation of α-Synuclein Mediating Apoptosis of Dopaminergic Neurons in Parkinson's Disease

TrkB Neurotrophic Activities Are Blocked by Α-Synuclein, Triggering Dopaminergic Cell Death in Parkinson's Disease.

Expression of Mutant but Not Wild-Type Α-Synuclein in SH-SY5Y Cells Induces Apoptosis and Autophagy: Implication for Regulation of Cell Death in Parkinson's Disease